John Overdeck’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-34,833
Closed -$1.03M 4882
2025
Q4
$1.03M Sell
34,833
-43,600
-56% -$1.21M ﹤0.01% 2894
2025
Q3
$1.98M Sell
78,433
-3,300
-4% -$80.4K ﹤0.01% 2136
2025
Q2
$1.96M Sell
81,733
-4,100
-5% -$95.1K ﹤0.01% 1847
2025
Q1
$1.97M Sell
85,833
-146,187
-63% -$3.53M ﹤0.01% 1748
2024
Q4
$5.87M Buy
232,020
+217,454
+1,493% +$5.51M 0.01% 1006
2024
Q3
$363K Buy
14,566
+1,333
+10% +$39.5K ﹤0.01% 2600
2024
Q2
$392K Sell
13,233
-28,225
-68% -$783K ﹤0.01% 2478
2024
Q1
$1.25M Buy
+41,458
New +$1.15M ﹤0.01% 1804

Other funds holding RTO

John Overdeck's RTO Position: Q1 2026 in Review

John Overdeck sold out of Rentokil (RTO) in Q1 2026, closing a stake of 34,833 shares — an estimated $1.03M sold.

John Overdeck first reported a position in RTO in Q1 2024 and held it in 8 quarters. The position peaked at $5.87M in Q4 2024. 283 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • John Overdeck reported no remaining Rentokil position as of Q1 2026 after selling out during the quarter.
  • John Overdeck sold 34,833 Rentokil shares in Q1 2026, an estimated $1.03M.
  • John Overdeck first reported a position in Rentokil in Q1 2024 and held it in 8 quarters.
  • John Overdeck's Rentokil position peaked at $5.87M in Q4 2024.
  • 283 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.